tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Cohen’s Point72 reports 5.2% passive stake in Design Therapeutics

Steven Cohen’s Point72 Asset Management disclosed a 5.2% stake in Design Therapeutics (DSGN), which represents over 2.94M shares. The filing with the SEC does not allow for activism.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1